Direct Thrombin Inhibitor [EPC]

Direct Thrombin Inhibitor [EPC] was reported 2449 times

Drugs of the Direct Thrombin Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 BURKITT'S LYMPHOMA STAGE IV 1 0.2500
1 ISCHAEMIC MITRAL REGURGITATION 2 0.2500
2 DISSEMINATED ESCHERICHIA INFECTION 1 0.2500
3 ADRENAL THROMBOSIS 3 0.1364
4 ARTERIOVENOUS FISTULA, ACQUIRED 2 0.1333
5 AUTOIMMUNE HEPARIN-INDUCED THROMBOCYTOPENIA 8 0.1270
6 THROMBOSIS WITH THROMBOCYTOPENIA SYNDROME 5 0.1190
7 OESOPHAGEAL INTRAMURAL HAEMATOMA 8 0.0762
8 BILE OUTPUT 1 0.0588
9 TRAUMATIC ARTHROPATHY 2 0.0556
10 LIVER TRANSPLANT FAILURE 3 0.0545
11 HEPARIN-INDUCED THROMBOCYTOPENIA 259 0.0525
12 COAGULATION TIME PROLONGED 77 0.0497
13 HEPARIN RESISTANCE 6 0.0492
14 VASCULAR ACCESS SITE HAEMATOMA 2 0.0476
15 FIBRIN 2 0.0465
16 COAGULATION TIME ABNORMAL 12 0.0400
17 COAGULATION TIME 1 0.0385
18 CAROTID ARTERY PERFORATION 1 0.0345
19 ILIAC ARTERY OCCLUSION 9 0.0327
20 ACTIVATED PARTIAL THROMBOPLASTIN TIME ABNORMAL 8 0.0324
21 MEDIASTINAL HAEMORRHAGE 3 0.0309
22 MEDIASTINAL HAEMATOMA 5 0.0301
23 INHIBITING ANTIBODIES 2 0.0286
24 REOCCLUSION 2 0.0256
25 CARDIOPULMONARY BYPASS 1 0.0256
26 ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED 10 0.0239
27 ANORECTAL VARICES 1 0.0238
28 HEPARIN-INDUCED THROMBOCYTOPENIA TEST POSITIVE 2 0.0238
29 COLONIC HAEMATOMA 2 0.0235
30 VENTRICULAR ASSIST DEVICE INSERTION 2 0.0235
31 VASCULAR STENT THROMBOSIS 47 0.0231
32 CORONARY VASCULAR GRAFT OCCLUSION 1 0.0227
33 TRACHEAL DEVIATION 2 0.0227
34 CEREBRAL HYPERPERFUSION SYNDROME 2 0.0220
35 CONTRAST ENCEPHALOPATHY 6 0.0217
36 CARDIAC PROCEDURE COMPLICATION 13 0.0214
37 DIFFICULT TO WEAN FROM VENTILATOR 1 0.0204
38 THORACIC HAEMORRHAGE 4 0.0200
39 HAEMORRHAGIC CEREBRAL INFARCTION 14 0.0199
40 VASCULAR STENT OCCLUSION 8 0.0199
41 PROTEIN C DECREASED 2 0.0194
42 VASCULAR GRAFT THROMBOSIS 2 0.0189
43 VASCULAR ACCESS SITE HAEMORRHAGE 3 0.0186
44 MEDICAL DEVICE SITE HAEMORRHAGE 5 0.0176
45 MICROEMBOLISM 2 0.0175
46 BLOOD FIBRINOGEN ABNORMAL 1 0.0175
47 INFERIOR VENA CAVAL OCCLUSION 2 0.0174
48 DRY GANGRENE 11 0.0173
49 ACHROMOBACTER INFECTION 2 0.0167
50 CENTRAL AUDITORY PROCESSING DISORDER 1 0.0167
51 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 84 0.0166
52 ACTIVATED PARTIAL THROMBOPLASTIN TIME 1 0.0164
53 COAGULATION FACTOR INCREASED 1 0.0164
54 BURKHOLDERIA TEST POSITIVE 2 0.0161
55 CONGENITAL ARTERIAL MALFORMATION 3 0.0156
56 RENAL VEIN THROMBOSIS 10 0.0148
57 CRITICAL ILLNESS POLYNEUROPATHY 1 0.0145
58 MYOCARDIAL STRAIN 2 0.0144
59 ARTERIOGRAM CORONARY ABNORMAL 1 0.0137
60 HEPATIC ARTERY THROMBOSIS 4 0.0137
61 VASCULAR PSEUDOANEURYSM 23 0.0132
62 CARDIAC VENTRICULAR THROMBOSIS 17 0.0132
63 THROMBOSIS IN DEVICE 43 0.0131
64 EXERCISE ELECTROCARDIOGRAM ABNORMAL 1 0.0120
65 VENOUS STENOSIS 3 0.0119
66 PUNCTURE SITE HAEMORRHAGE 8 0.0113
67 ANTITHROMBIN III DEFICIENCY 1 0.0112
68 OPERATIVE HAEMORRHAGE 5 0.0112
69 BLOOD ANTIDIURETIC HORMONE INCREASED 1 0.0108
70 THROMBOTIC CEREBRAL INFARCTION 4 0.0106
71 ANASTOMOTIC HAEMORRHAGE 2 0.0105
72 HYPOFIBRINOGENAEMIA 10 0.0101
73 CARDIAC CIRRHOSIS 1 0.0097
74 ARTERY DISSECTION 4 0.0097
75 HAEMORRHAGIC INFARCTION 5 0.0091
76 ADRENAL CYST 1 0.0091
77 COAGULATION TIME SHORTENED 3 0.0090
78 ADRENAL HAEMORRHAGE 5 0.0089
79 FALSE NEGATIVE INVESTIGATION RESULT 6 0.0085
80 TRACHEAL HAEMORRHAGE 3 0.0085
81 ARTERIAL RESTENOSIS 1 0.0085
82 VENA CAVA THROMBOSIS 14 0.0084
83 CEREBRAL VENOUS SINUS THROMBOSIS 7 0.0083
84 PHARYNGEAL HAEMORRHAGE 10 0.0081
85 THROMBIN TIME PROLONGED 2 0.0081
86 AXILLARY VEIN THROMBOSIS 3 0.0081
87 PERIPHERAL ARTERY THROMBOSIS 11 0.0078
88 MESENTERIC ARTERY THROMBOSIS 3 0.0078
89 ACTINOMYCES TEST POSITIVE 1 0.0078
90 CATHETER SITE HAEMORRHAGE 19 0.0076
91 CEREBROVASCULAR SPASM 1 0.0076
92 CORONARY ARTERY REOCCLUSION 1 0.0076
93 HAEMORRHAGIC TRANSFORMATION STROKE 11 0.0073
94 CARDIAC VENTRICULAR DISORDER 3 0.0073
95 ARTERIAL THROMBOSIS LIMB 3 0.0072
96 CRANIAL NERVE PALSIES MULTIPLE 1 0.0071
97 WRONG PRODUCT STORED 2 0.0070
98 PELVIC VENOUS THROMBOSIS 10 0.0070
99 BASAL GANGLIA STROKE 1 0.0069
100 AORTIC THROMBOSIS 8 0.0069
101 PERICARDIAL HAEMORRHAGE 15 0.0069
102 CATHETER SITE HAEMATOMA 2 0.0068
103 CARDIAC ASTHMA 1 0.0067
104 POST THROMBOTIC SYNDROME 3 0.0067
105 EMBOLISM ARTERIAL 8 0.0067
106 KOUNIS SYNDROME 15 0.0066
107 PRIMARY ADRENAL INSUFFICIENCY 2 0.0066
108 RETROPERITONEAL HAEMORRHAGE 16 0.0065
109 CORONARY ARTERY THROMBOSIS 13 0.0064
110 BRONCHIAL HAEMORRHAGE 2 0.0064
111 CORONARY REVASCULARISATION 1 0.0063
112 CHRONIC HEPATITIS B 2 0.0063
113 PERFORATION 5 0.0062
114 RUPTURED CEREBRAL ANEURYSM 4 0.0062
115 INCISION SITE HAEMORRHAGE 5 0.0062
116 ABDOMINAL WALL HAEMATOMA 12 0.0061
117 BASILAR ARTERY OCCLUSION 1 0.0060
118 PNEUMONIA ESCHERICHIA 2 0.0059
119 ISCHAEMIC HEPATITIS 8 0.0058
120 ANTI-PLATELET ANTIBODY POSITIVE 1 0.0058
121 FAT EMBOLISM 2 0.0056
122 GLOMERULONEPHRITIS PROLIFERATIVE 2 0.0055
123 RIGHT VENTRICULAR DYSFUNCTION 6 0.0054
124 LUNG INFECTION PSEUDOMONAL 3 0.0054
125 KLEBSIELLA SEPSIS 6 0.0053
126 HEPATIC INFARCTION 2 0.0053
127 ANTIPHOSPHOLIPID ANTIBODIES POSITIVE 3 0.0052
128 CEREBRAL ARTERIOSCLEROSIS 2 0.0052
129 EXTREMITY NECROSIS 9 0.0052
130 ACINETOBACTER TEST POSITIVE 1 0.0052
131 HYPOCOAGULABLE STATE 5 0.0051
132 CEREBELLAR STROKE 2 0.0051
133 DEVICE RELATED THROMBOSIS 5 0.0051
134 PERIPHERAL ISCHAEMIA 20 0.0049
135 PULMONARY CALCIFICATION 2 0.0048
136 BREAST NECROSIS 1 0.0048
137 VASCULAR STENT STENOSIS 2 0.0048
138 ANOXIC ENCEPHALOPATHY 3 0.0047
139 PULMONARY ALVEOLAR HAEMORRHAGE 26 0.0046
140 CARDIAC MYXOMA 1 0.0046
141 JUGULAR VEIN THROMBOSIS 8 0.0045
142 ELECTROCARDIOGRAM ST-T SEGMENT ABNORMAL 2 0.0045
143 SUBCLAVIAN VEIN THROMBOSIS 5 0.0044
144 BLOOD FIBRINOGEN DECREASED 5 0.0044
145 ANEURYSM RUPTURED 4 0.0044
146 CARDIAC PERFORATION 1 0.0043
147 PANCREATITIS HAEMORRHAGIC 2 0.0043
148 AGNOSIA 1 0.0042
149 HAEMOTHORAX 12 0.0041
150 DERMATITIS HERPETIFORMIS 1 0.0041
151 ARTERIOVENOUS FISTULA 2 0.0041
152 EVANS SYNDROME 2 0.0041
153 INTERNATIONAL NORMALISED RATIO INCREASED 114 0.0040
154 TRANSPLANT EVALUATION 2 0.0039
155 SUPRAPUBIC PAIN 2 0.0039
156 BRAIN STEM INFARCTION 4 0.0039
157 CEREBRAL ARTERY THROMBOSIS 2 0.0039
158 ANTICOAGULATION DRUG LEVEL BELOW THERAPEUTIC 3 0.0039
159 CATHETER SITE THROMBOSIS 1 0.0036
160 CARDIAC TAMPONADE 17 0.0036
161 COR PULMONALE ACUTE 1 0.0036
162 ENCEPHALOMALACIA 2 0.0036
163 INTRACRANIAL HAEMATOMA 2 0.0036
164 PNEUMATOSIS INTESTINALIS 10 0.0035
165 GANGRENE 21 0.0035
166 SICK SINUS SYNDROME 4 0.0035
167 SKIN NECROSIS 18 0.0035
168 ABDOMINAL WALL DISORDER 1 0.0034
169 RESPIRATORY TRACT HAEMORRHAGE 2 0.0034
170 HAEMATOMA MUSCLE 4 0.0033
171 SUBARACHNOID HAEMORRHAGE 34 0.0033
172 PROCEDURAL HAEMORRHAGE 13 0.0033
173 ENTEROBACTER BACTERAEMIA 1 0.0033
174 CORONARY ARTERY SURGERY 1 0.0032
175 COAGULOPATHY 53 0.0032
176 ABDOMINAL COMPARTMENT SYNDROME 2 0.0031
177 DISSEMINATED INTRAVASCULAR COAGULATION 44 0.0031
178 CONTINUOUS HAEMODIAFILTRATION 3 0.0031
179 COAGULATION FACTOR V LEVEL DECREASED 1 0.0031
180 ACUTE LEFT VENTRICULAR FAILURE 2 0.0030
181 MUCOSAL ULCERATION 3 0.0030
182 POST PROCEDURAL HAEMATOMA 5 0.0030
183 BRAIN MASS 1 0.0030
184 CARDIOGENIC SHOCK 42 0.0029
185 BASAL GANGLIA INFARCTION 1 0.0029
186 VENOUS THROMBOSIS LIMB 6 0.0029
187 ATRIAL THROMBOSIS 6 0.0029
188 PROTHROMBIN TIME SHORTENED 4 0.0029
189 PROPOFOL INFUSION SYNDROME 2 0.0028
190 FOETAL HEART RATE DECELERATION ABNORMALITY 2 0.0028
191 DIALYSIS RELATED COMPLICATION 1 0.0028
192 DELAYED GRAFT FUNCTION 2 0.0028
193 CEREBRAL MASS EFFECT 1 0.0028
194 ARRHYTHMIA SUPRAVENTRICULAR 3 0.0027
195 FINGER AMPUTATION 2 0.0027
196 CORNEAL DEPOSITS 2 0.0027
197 PULMONARY HAEMORRHAGE 21 0.0027
198 ARTERIAL INJURY 2 0.0027
199 CORNEAL REFLEX DECREASED 1 0.0027
200 CATHETER SITE RELATED REACTION 2 0.0027
201 ARTERIAL HAEMORRHAGE 3 0.0026
202 HYPERCOAGULATION 5 0.0026
203 PUPILS UNEQUAL 3 0.0026
204 ALKALOSIS 1 0.0026
205 PULMONARY ARTERY THROMBOSIS 2 0.0026
206 PERIPHERAL EMBOLISM 3 0.0026
207 MUCOSAL HAEMORRHAGE 3 0.0026
208 ARTERIAL THROMBOSIS 5 0.0026
209 BLUE TOE SYNDROME 1 0.0026
210 DEPENDENCE ON RESPIRATOR 1 0.0025
211 ANTIPHOSPHOLIPID SYNDROME 4 0.0025
212 BLEEDING TIME PROLONGED 3 0.0025
213 CARDIAC DEATH 3 0.0025
214 HAEMORRHAGE INTRACRANIAL 37 0.0025
215 ANTIBIOTIC LEVEL ABOVE THERAPEUTIC 1 0.0025
216 SPUTUM CULTURE POSITIVE 2 0.0025
217 VENTRICULAR FIBRILLATION 27 0.0024
218 DENTAL FISTULA 1 0.0024
219 SUPERFICIAL VEIN THROMBOSIS 2 0.0024
220 CEREBRAL INFARCTION 58 0.0024
221 CEREBELLAR INFARCTION 4 0.0024
222 SHOCK HAEMORRHAGIC 19 0.0023
223 HEPATIC HAEMORRHAGE 2 0.0023
224 CITROBACTER INFECTION 1 0.0023
225 CORONARY ARTERY DISSECTION 2 0.0023
226 PUPIL FIXED 4 0.0023
227 STAPHYLOCOCCAL BACTERAEMIA 10 0.0023
228 COMPARTMENT SYNDROME 6 0.0023
229 HYPERLEUKOCYTOSIS 2 0.0023
230 PARVOVIRUS B19 INFECTION 2 0.0022
231 BLOOD ALKALINE PHOSPHATASE ABNORMAL 2 0.0022
232 CEREBRAL MICROHAEMORRHAGE 1 0.0022
233 SUBDURAL HAEMORRHAGE 6 0.0022
234 PROTHROMBIN TIME PROLONGED 13 0.0022
235 PRODUCT APPEARANCE CONFUSION 2 0.0022
236 PULSELESS ELECTRICAL ACTIVITY 9 0.0022
237 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 19 0.0021
238 BRONCHIAL OBSTRUCTION 3 0.0021
239 PERIPHERAL ARTERY OCCLUSION 3 0.0021
240 ANAPHYLACTOID SHOCK 1 0.0021
241 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 7 0.0021
242 CRANIAL NERVE PARALYSIS 1 0.0021
243 NEUTROPENIC INFECTION 2 0.0021
244 ANAEMIA NEONATAL 1 0.0021
245 RENAL INFARCT 3 0.0021
246 POST PROCEDURAL HAEMORRHAGE 24 0.0021
247 CROSS SENSITIVITY REACTION 2 0.0021
248 CEREBRAL ARTERY STENOSIS 1 0.0020
249 EMBOLISM 17 0.0020
250 VENOUS THROMBOSIS 8 0.0020
251 ENCEPHALITIS HERPES 1 0.0020
252 RIGHT VENTRICULAR FAILURE 14 0.0020
253 EMBOLIC STROKE 7 0.0020
254 SECONDARY ADRENOCORTICAL INSUFFICIENCY 3 0.0020
255 FALSE POSITIVE INVESTIGATION RESULT 2 0.0020
256 EMBOLISM VENOUS 6 0.0020
257 CATHETER RELATED INFECTION 2 0.0020
258 FIBRIN D DIMER INCREASED 7 0.0020
259 ENDOCARDITIS 10 0.0019
260 ENZYME ABNORMALITY 1 0.0019
261 HAEMODYNAMIC INSTABILITY 14 0.0018
262 INTESTINAL ISCHAEMIA 10 0.0018
263 DRUG EFFECT PROLONGED 1 0.0018
264 ADENOCARCINOMA 4 0.0018
265 CATHETER RELATED COMPLICATION 2 0.0018
266 INTERNATIONAL NORMALISED RATIO ABNORMAL 6 0.0017
267 MULTI-ORGAN FAILURE 30 0.0017
268 ISCHAEMIC CEREBRAL INFARCTION 2 0.0017
269 ENDOTRACHEAL INTUBATION COMPLICATION 1 0.0017
270 INTRA-ABDOMINAL HAEMORRHAGE 4 0.0017
271 CORONARY ARTERY RESTENOSIS 1 0.0017
272 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 2 0.0017
273 DIABETES INSIPIDUS 4 0.0017
274 HAEMORRHAGE 172 0.0016
275 INTRACARDIAC THROMBUS 5 0.0016
276 BRAIN DEATH 5 0.0016
277 AMPUTATION 2 0.0016
278 WHITE MATTER LESION 2 0.0016
279 ARTERITIS 1 0.0016
280 MECHANICAL VENTILATION 3 0.0016
281 MALLORY-WEISS SYNDROME 2 0.0016
282 SUBCUTANEOUS HAEMATOMA 2 0.0016
283 APGAR SCORE LOW 2 0.0016
284 ENTEROCOCCUS TEST POSITIVE 1 0.0015
285 ALLERGIC OEDEMA 1 0.0015
286 BICYTOPENIA 3 0.0015
287 INFUSION SITE HAEMORRHAGE 5 0.0015
288 PACKED RED BLOOD CELL TRANSFUSION 2 0.0015
289 EMBOLIC CEREBRAL INFARCTION 1 0.0015
290 POSTPARTUM HAEMORRHAGE 2 0.0015
291 EAR HAEMORRHAGE 3 0.0015
292 INTERNATIONAL NORMALISED RATIO DECREASED 6 0.0015
293 BLOOD LACTATE DEHYDROGENASE ABNORMAL 1 0.0015
294 COMPUTERISED TOMOGRAM THORAX ABNORMAL 1 0.0015
295 LEG AMPUTATION 6 0.0015
296 ECHOCARDIOGRAM ABNORMAL 2 0.0014
297 ACUTE MYOCARDIAL INFARCTION 42 0.0014
298 THROMBOTIC THROMBOCYTOPENIC PURPURA 5 0.0014
299 CEREBELLAR HAEMORRHAGE 2 0.0014
300 CEREBRAL HAEMORRHAGE 50 0.0014
301 CARDIAC ENZYMES INCREASED 1 0.0014
302 CHYLOTHORAX 1 0.0014
303 OESOPHAGEAL VARICES HAEMORRHAGE 3 0.0014
304 DYSLALIA 1 0.0014
305 BLOOD BILIRUBIN UNCONJUGATED INCREASED 1 0.0014
306 FOOT AMPUTATION 2 0.0014
307 DYSPNOEA PAROXYSMAL NOCTURNAL 1 0.0014
308 VENTRICULAR ARRHYTHMIA 5 0.0014
309 RETROPERITONEAL HAEMATOMA 3 0.0014
310 ENTEROCOLITIS HAEMORRHAGIC 2 0.0014
311 MULTIPLE ORGAN DYSFUNCTION SYNDROME 38 0.0013
312 BRAIN HERNIATION 4 0.0013
313 CREATININE RENAL CLEARANCE INCREASED 1 0.0013
314 BRAIN STEM SYNDROME 1 0.0013
315 DISTRIBUTIVE SHOCK 3 0.0013
316 THROMBOPHLEBITIS SUPERFICIAL 4 0.0013
317 ISCHAEMIA 6 0.0013
318 PROCEDURAL COMPLICATION 10 0.0013
319 DEBRIDEMENT 1 0.0013
320 NEUROLOGICAL DECOMPENSATION 3 0.0013
321 HAEMORRHAGIC STROKE 10 0.0013
322 BLOOD FIBRINOGEN INCREASED 1 0.0013
323 IDIOPATHIC THROMBOCYTOPENIC PURPURA 2 0.0013
324 ELECTROMECHANICAL DISSOCIATION 1 0.0013
325 ANGIOPATHY 7 0.0012
326 DEEP VEIN THROMBOSIS 81 0.0012
327 BASAL GANGLIA HAEMORRHAGE 1 0.0012
328 ANAL ULCER 1 0.0012
329 THROMBOSIS 98 0.0012
330 INTRAVENTRICULAR HAEMORRHAGE 3 0.0012
331 CAROTID ARTERY THROMBOSIS 1 0.0012
332 INCORRECT DRUG ADMINISTRATION RATE 5 0.0012
333 GAZE PALSY 2 0.0012
334 DRUG RESISTANCE 30 0.0012
335 CEREBRAL ISCHAEMIA 6 0.0012
336 HAEMATOMA 30 0.0012
337 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 3 0.0011
338 HAEMORRHAGIC ANAEMIA 5 0.0011
339 CEREBELLAR ATROPHY 1 0.0011
340 ABDOMINAL SEPSIS 1 0.0011
341 ENTEROCUTANEOUS FISTULA 1 0.0011
342 CARDIAC OUTPUT DECREASED 1 0.0011
343 LUNG INFILTRATION 10 0.0011
344 GASTROINTESTINAL HAEMORRHAGE 93 0.0011
345 ANAEMIA OF CHRONIC DISEASE 1 0.0011
346 ARTERIOVENOUS MALFORMATION 1 0.0011
347 PNEUMONIA KLEBSIELLA 2 0.0011
348 NECROSIS 6 0.0011
349 INTRACRANIAL PRESSURE INCREASED 6 0.0011
350 ENDOTRACHEAL INTUBATION 3 0.0011
351 ISCHAEMIC STROKE 19 0.0011
352 DUODENAL ULCER HAEMORRHAGE 3 0.0010
353 COR PULMONALE 1 0.0010
354 CEREBELLAR ATAXIA 1 0.0010
355 ACTINOMYCOSIS 1 0.0010
356 ADRENAL DISORDER 2 0.0010
357 COMA SCALE ABNORMAL 3 0.0010
358 VENTRICULAR TACHYCARDIA 17 0.0010
359 DUODENAL PERFORATION 1 0.0010
360 COLON ADENOMA 1 0.0010
361 ORGAN FAILURE 4 0.0010
362 QUADRIPLEGIA 2 0.0010
363 CAPILLARY LEAK SYNDROME 2 0.0010
364 INTERNATIONAL NORMALISED RATIO FLUCTUATION 2 0.0010
365 BONE MARROW OEDEMA 1 0.0010
366 SKIN INDURATION 2 0.0010
367 LIVEDO RETICULARIS 2 0.0010
368 MOUTH HAEMORRHAGE 7 0.0010
369 BRAIN OEDEMA 12 0.0009
370 ENTEROCOCCAL BACTERAEMIA 1 0.0009
371 VENTRICULAR HYPOKINESIA 3 0.0009
372 FACIAL PALSY 2 0.0009
373 ACINETOBACTER INFECTION 1 0.0009
374 PERICARDIAL EFFUSION 21 0.0009
375 SUBDURAL HAEMATOMA 13 0.0009
376 COMPLEX PARTIAL SEIZURES 1 0.0009
377 CARDIAC HYPERTROPHY 1 0.0009
378 ATRIOVENTRICULAR BLOCK COMPLETE 6 0.0009
379 COLITIS ISCHAEMIC 6 0.0009
380 BLOOD LOSS ANAEMIA 2 0.0009
381 COMPLICATIONS OF TRANSPLANTED KIDNEY 2 0.0009
382 BLOODY DISCHARGE 1 0.0009
383 APLASIA PURE RED CELL 3 0.0009
384 PNEUMONIA BACTERIAL 8 0.0009
385 LEFT VENTRICULAR FAILURE 3 0.0009
386 DIFFUSE ALVEOLAR DAMAGE 1 0.0009
387 ACUTE PRERENAL FAILURE 1 0.0009
388 HAEMOLYTIC URAEMIC SYNDROME 2 0.0009
389 PULMONARY EMBOLISM 81 0.0009
390 THROMBOCYTOPENIA 95 0.0008
391 HEMIPLEGIA 7 0.0008
392 PULSE ABSENT 4 0.0008
393 HYPOVOLAEMIC SHOCK 4 0.0008
394 ATELECTASIS 8 0.0008
395 SHOCK 19 0.0008
396 BLOOD IMMUNOGLOBULIN G INCREASED 1 0.0008
397 CEREBRAL ARTERY EMBOLISM 1 0.0008
398 EJECTION FRACTION ABNORMAL 1 0.0008
399 INFLAMMATORY MARKER INCREASED 4 0.0008
400 VENTRICULAR HYPERTROPHY 2 0.0008
401 VASODILATATION 2 0.0008
402 PLATELET DISORDER 2 0.0008
403 PURPURA 7 0.0008
404 HAEMATEMESIS 20 0.0008
405 HAEMORRHAGE URINARY TRACT 2 0.0008
406 BRONCHIAL SECRETION RETENTION 1 0.0008
407 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 1 0.0008
408 BLOOD BILIRUBIN ABNORMAL 1 0.0008
409 MELAENA 17 0.0008
410 MUCORMYCOSIS 2 0.0008
411 ANAEMIA POSTOPERATIVE 1 0.0008
412 DRUG CLEARANCE DECREASED 1 0.0008
413 RESPIRATORY ACIDOSIS 3 0.0008
414 CARDIOACTIVE DRUG LEVEL INCREASED 1 0.0008
415 EXFOLIATIVE RASH 2 0.0008
416 ATRIAL FLUTTER 6 0.0008
417 CARDIAC FAILURE ACUTE 5 0.0007
418 AREFLEXIA 2 0.0007
419 GASTROINTESTINAL INJURY 2 0.0007
420 ABDOMINAL RIGIDITY 2 0.0007
421 ACUTE RESPIRATORY DISTRESS SYNDROME 13 0.0007
422 INFARCTION 5 0.0007
423 POST PROCEDURAL COMPLICATION 14 0.0007
424 PULMONARY HYPERTENSION 15 0.0007
425 UPPER GASTROINTESTINAL HAEMORRHAGE 12 0.0007
426 SKIN HYPERTROPHY 2 0.0007
427 IMMUNE THROMBOCYTOPENIC PURPURA 2 0.0007
428 CARDIAC ARREST 58 0.0007
429 NEUTROPENIC SEPSIS 5 0.0007
430 GASTRIC HAEMORRHAGE 8 0.0007
431 PNEUMOTHORAX 11 0.0007
432 STRESS CARDIOMYOPATHY 4 0.0007
433 RESPIRATORY FAILURE 50 0.0007
434 HYPERTRIGLYCERIDAEMIA 4 0.0007
435 HAEMOPTYSIS 19 0.0007
436 ACUTE RESPIRATORY FAILURE 13 0.0007
437 ANGIOPLASTY 1 0.0007
438 INFUSION SITE REACTION 2 0.0007
439 SEPTIC SHOCK 29 0.0007
440 HYPERCAPNIA 2 0.0007
441 NEPHROGENIC SYSTEMIC FIBROSIS 2 0.0007
442 TROPONIN INCREASED 5 0.0007
443 IMMUNE THROMBOCYTOPENIA 3 0.0007
444 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 1 0.0007
445 RENAL FAILURE CHRONIC 5 0.0006
446 FIBROSIS 2 0.0006
447 SKIN TIGHTNESS 3 0.0006
448 RENAL FAILURE ACUTE 27 0.0006
449 DIALYSIS 9 0.0006
450 DRUG EFFECT INCREASED 2 0.0006
451 TRICUSPID VALVE INCOMPETENCE 5 0.0006
452 DISINHIBITION 1 0.0006
453 ENTEROCOCCAL INFECTION 3 0.0006
454 PORTAL VEIN THROMBOSIS 2 0.0006
455 ANGINA UNSTABLE 4 0.0006
456 LEUKOCYTOSIS 11 0.0006
457 STAPHYLOCOCCAL SEPSIS 3 0.0006
458 COLONIC POLYP 1 0.0006
459 ANEURYSM 3 0.0006
460 ANTIBODY TEST POSITIVE 1 0.0006
461 HYPOXIA 21 0.0006
462 CEREBRAL HAEMATOMA 2 0.0006
463 SUPRAVENTRICULAR EXTRASYSTOLES 2 0.0006
464 HEMIPARESIS 10 0.0006
465 HEPATIC FUNCTION ABNORMAL 22 0.0006
466 SUDDEN CARDIAC DEATH 2 0.0006
467 CORONARY ARTERY OCCLUSION 8 0.0006
468 PERIPHERAL VASCULAR DISORDER 3 0.0006
469 CHOREA 1 0.0006
470 BLOOD CHLORIDE INCREASED 1 0.0006
471 CAROTID ARTERY STENOSIS 2 0.0006
472 TYPE I HYPERSENSITIVITY 2 0.0006
473 BLOOD LACTATE DEHYDROGENASE INCREASED 9 0.0006
474 HAEMORRHAGE SUBCUTANEOUS 2 0.0006
475 AORTIC VALVE STENOSIS 1 0.0006
476 CARDIAC ABLATION 1 0.0006
477 DEVICE ALARM ISSUE 1 0.0006
478 CEREBRAL VENOUS THROMBOSIS 1 0.0006
479 FLUID OVERLOAD 8 0.0005
480 CONTRAST MEDIA ALLERGY 1 0.0005
481 CONDUCTION DISORDER 1 0.0005
482 DRUG LEVEL BELOW THERAPEUTIC 3 0.0005
483 UNRESPONSIVE TO STIMULI 14 0.0005
484 CATHETER PLACEMENT 1 0.0005
485 ACUTE PULMONARY OEDEMA 3 0.0005
486 CIRCULATORY COLLAPSE 9 0.0005
487 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 2 0.0005
488 SUPRAVENTRICULAR TACHYCARDIA 5 0.0005
489 OESOPHAGEAL DISORDER 2 0.0005
490 PRODUCT LABEL CONFUSION 3 0.0005
491 ATROPHY 1 0.0005
492 CARDIOPULMONARY FAILURE 2 0.0005
493 HYPOVOLAEMIA 3 0.0005
494 CONCOMITANT DISEASE PROGRESSION 1 0.0005
495 PLATELET COUNT DECREASED 54 0.0005
496 BACTERAEMIA 6 0.0005
497 EMPYEMA 1 0.0005
498 DEEP VEIN THROMBOSIS POSTOPERATIVE 1 0.0005
499 PLATELET COUNT ABNORMAL 3 0.0005
500 DECUBITUS ULCER 4 0.0005
501 PARALYSIS 7 0.0005
502 ANAPHYLACTOID REACTION 2 0.0005
503 DIVERTICULAR PERFORATION 1 0.0005
504 OLIGURIA 3 0.0005
505 AORTIC DISSECTION 2 0.0005
506 LIVE BIRTH 4 0.0005
507 BLOOD UREA INCREASED 8 0.0005
508 ATRIAL TACHYCARDIA 1 0.0005
509 ALANINE AMINOTRANSFERASE ABNORMAL 1 0.0005
510 DEVICE CONNECTION ISSUE 1 0.0005
511 RESPIRATORY DISTRESS 13 0.0005
512 AORTIC VALVE INCOMPETENCE 2 0.0005
513 HEPATIC FAILURE 14 0.0005
514 TOXIC EPIDERMAL NECROLYSIS 7 0.0005
515 CERVICAL DYSPLASIA 1 0.0005
516 HAEMOGLOBIN DECREASED 47 0.0005
517 STAPHYLOCOCCAL INFECTION 15 0.0005
518 ELECTROCARDIOGRAM T WAVE INVERSION 1 0.0005
519 ABDOMINAL ABSCESS 2 0.0005
520 EJECTION FRACTION DECREASED 7 0.0004
521 CYTOMEGALOVIRUS VIRAEMIA 2 0.0004
522 CALCINOSIS 1 0.0004
523 LIVER FUNCTION TEST ABNORMAL 13 0.0004
524 HAEMOLYTIC ANAEMIA 4 0.0004
525 DIVERTICULUM INTESTINAL HAEMORRHAGIC 1 0.0004
526 BLOOD ALKALINE PHOSPHATASE INCREASED 11 0.0004
527 MITRAL VALVE INCOMPETENCE 5 0.0004
528 COMPUTERISED TOMOGRAM ABNORMAL 1 0.0004
529 ACUTE HEPATIC FAILURE 6 0.0004
530 ECCHYMOSIS 3 0.0004
531 PERIPHERAL COLDNESS 6 0.0004
532 DISEASE COMPLICATION 2 0.0004
533 APHTHOUS STOMATITIS 1 0.0004
534 BILIRUBIN CONJUGATED INCREASED 1 0.0004
535 DUODENAL ULCER 3 0.0004
536 SINUS TACHYCARDIA 6 0.0004
537 ATRIAL FIBRILLATION 41 0.0004
538 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 23 0.0004
539 KIDNEY TRANSPLANT REJECTION 2 0.0004
540 PLEURAL EFFUSION 25 0.0004
541 THROMBOTIC MICROANGIOPATHY 4 0.0004
542 BREATH ODOUR 1 0.0004
543 HAEMATURIA 14 0.0004
544 RESPIRATORY DEPRESSION 5 0.0004
545 LIVER INJURY 10 0.0004
546 BLOOD BILIRUBIN INCREASED 11 0.0004
547 CARDIO-RESPIRATORY ARREST 17 0.0004
548 LOWER GASTROINTESTINAL HAEMORRHAGE 3 0.0004
549 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 1 0.0004
550 ACUTE PSYCHOSIS 1 0.0004
551 HAEMATOCRIT DECREASED 8 0.0004
552 DEVICE INFUSION ISSUE 1 0.0004
553 HYPERNATRAEMIA 2 0.0004
554 EPISTAXIS 30 0.0004
555 EOSINOPHILIA 7 0.0004
556 KLEBSIELLA INFECTION 2 0.0004
557 ASPARTATE AMINOTRANSFERASE INCREASED 21 0.0004
558 DYSLIPIDAEMIA 2 0.0004
559 ACIDOSIS 3 0.0004
560 FEMORAL NECK FRACTURE 2 0.0004
561 AORTIC ARTERIOSCLEROSIS 1 0.0004
562 HAEMOLYSIS 3 0.0004
563 BLOOD CHLORIDE DECREASED 1 0.0004
564 DRUG TITRATION ERROR 1 0.0004
565 PERITONITIS 8 0.0004
566 TRANSFUSION 4 0.0004
567 BLOOD ALBUMIN DECREASED 3 0.0004
568 LOW BIRTH WEIGHT BABY 3 0.0004
569 AGRANULOCYTOSIS 7 0.0004
570 TRANSPLANT REJECTION 3 0.0004
571 RECTAL HAEMORRHAGE 16 0.0004
572 BLOOD SODIUM INCREASED 1 0.0004
573 APPLICATION SITE HAEMORRHAGE 1 0.0004
574 PREMATURE BABY 11 0.0004
575 ACUTE CORONARY SYNDROME 3 0.0004
576 RASH MACULO-PAPULAR 8 0.0004
577 ATRIAL SEPTAL DEFECT 3 0.0004
578 HAEMODIALYSIS 3 0.0004
579 INFUSION SITE ERYTHEMA 3 0.0004
580 CEREBRAL THROMBOSIS 1 0.0004
581 VENTRICULAR SEPTAL DEFECT 2 0.0003
582 ANURIA 3 0.0003
583 SKIN DISCOLOURATION 16 0.0003
584 HYPERVENTILATION 2 0.0003
585 METABOLIC DISORDER 2 0.0003
586 ABORTION 1 0.0003
587 LACTIC ACIDOSIS 11 0.0003
588 HYPOTENSION 68 0.0003
589 RHABDOMYOLYSIS 14 0.0003
590 CEREBROVASCULAR DISORDER 1 0.0003
591 SEPSIS 37 0.0003
592 CORONARY ARTERY DISEASE 10 0.0003
593 ADRENAL INSUFFICIENCY 4 0.0003
594 ATRIOVENTRICULAR BLOCK SECOND DEGREE 1 0.0003
595 CHEST X-RAY ABNORMAL 1 0.0003
596 DUODENITIS 1 0.0003
597 ALANINE AMINOTRANSFERASE INCREASED 20 0.0003
598 UROSEPSIS 3 0.0003
599 LARYNGEAL OEDEMA 2 0.0003
600 MENTAL STATUS CHANGES 9 0.0003
601 DIASTOLIC DYSFUNCTION 1 0.0003
602 INFUSION SITE EXTRAVASATION 2 0.0003
603 BLOOD PRESSURE DECREASED 21 0.0003
604 GAMMA-GLUTAMYLTRANSFERASE INCREASED 7 0.0003
605 BLADDER PAIN 1 0.0003
606 RENAL FAILURE 41 0.0003
607 RENAL TUBULAR NECROSIS 3 0.0003
608 PRODUCT PREPARATION ISSUE 2 0.0003
609 BRADYCARDIA 16 0.0003
610 RESPIRATORY DISORDER 9 0.0003
611 HYPOTHERMIA 3 0.0003
612 DRUG TOXICITY 4 0.0003
613 NEUTROPHIL COUNT INCREASED 3 0.0003
614 BRONCHOPNEUMONIA 1 0.0003
615 PULMONARY OEDEMA 13 0.0003
616 HYPERBILIRUBINAEMIA 3 0.0003
617 BLOOD CREATININE ABNORMAL 1 0.0003
618 DELIRIUM 10 0.0003
619 PRESYNCOPE 7 0.0003
620 PETECHIAE 3 0.0003
621 AORTIC STENOSIS 1 0.0003
622 CARDIAC FAILURE 23 0.0003
623 DEVICE OCCLUSION 4 0.0003
624 DEPRESSIVE SYMPTOM 1 0.0003
625 LYMPHOCYTE COUNT DECREASED 5 0.0003
626 THERAPEUTIC RESPONSE DECREASED 17 0.0003
627 PNEUMONIA ASPIRATION 7 0.0003
628 DEPRESSED LEVEL OF CONSCIOUSNESS 11 0.0003
629 ANAEMIA 53 0.0003
630 APPARENT DEATH 1 0.0003
631 BONE LESION 1 0.0003
632 ALTERED STATE OF CONSCIOUSNESS 6 0.0003
633 CAROTID ARTERY OCCLUSION 1 0.0003
634 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 7 0.0003
635 ANAPHYLACTIC REACTION 15 0.0003
636 MEDICAL DEVICE COMPLICATION 2 0.0003
637 DRUG EFFECT LESS THAN EXPECTED 4 0.0003
638 MALNUTRITION 3 0.0003
639 CHRONIC SINUSITIS 1 0.0003
640 ANHEDONIA 7 0.0003
641 COLITIS 10 0.0003
642 RENAL IMPAIRMENT 22 0.0003
643 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
644 LIPASE INCREASED 2 0.0003
645 DRUG INEFFECTIVE 344 0.0003
646 FEAR 7 0.0003
647 ATRIOVENTRICULAR BLOCK 2 0.0003
648 VASCULITIS 3 0.0003
649 APNOEA 2 0.0003
650 HYPERKALAEMIA 9 0.0003
651 INJURY 18 0.0003
652 EPIGASTRIC DISCOMFORT 1 0.0003
653 TORSADE DE POINTES 2 0.0003
654 ARTERIAL OCCLUSIVE DISEASE 2 0.0003
655 CYANOSIS 4 0.0003
656 TREATMENT FAILURE 21 0.0003
657 CREATININE RENAL CLEARANCE DECREASED 1 0.0002
658 ARTERIOSPASM CORONARY 1 0.0002
659 CARDIAC FAILURE CONGESTIVE 20 0.0002
660 LIVER DISORDER 11 0.0002
661 GLOMERULAR FILTRATION RATE DECREASED 3 0.0002
662 DEMYELINATION 1 0.0002
663 SMALL INTESTINAL OBSTRUCTION 3 0.0002
664 CONGESTIVE CARDIOMYOPATHY 1 0.0002
665 OFF LABEL USE 207 0.0002
666 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
667 ACUTE KIDNEY INJURY 36 0.0002
668 PYELONEPHRITIS 2 0.0002
669 BLOOD CREATININE INCREASED 15 0.0002
670 URINE OUTPUT DECREASED 2 0.0002
671 BLOOD CALCIUM INCREASED 2 0.0002
672 DYSPHEMIA 1 0.0002
673 RESPIRATORY RATE INCREASED 2 0.0002
674 INCORRECT ROUTE OF DRUG ADMINISTRATION 8 0.0002
675 TACHYPNOEA 3 0.0002
676 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
677 GINGIVAL BLEEDING 3 0.0002
678 PATHOGEN RESISTANCE 2 0.0002
679 HAEMATOCHEZIA 12 0.0002
680 NEPHROPATHY 2 0.0002
681 DEFORMITY 2 0.0002
682 FLANK PAIN 2 0.0002
683 DISEASE RECURRENCE 10 0.0002
684 WHITE BLOOD CELL COUNT INCREASED 8 0.0002
685 DRUG INTERACTION 33 0.0002
686 TRANSIENT ISCHAEMIC ATTACK 7 0.0002
687 PHARYNGEAL SWELLING 2 0.0002
688 ASCITES 6 0.0002
689 BRAIN INJURY 2 0.0002
690 CORONARY ARTERY STENOSIS 1 0.0002
691 CORONARY ARTERIAL STENT INSERTION 1 0.0002
692 DEVICE FAILURE 3 0.0002
693 BLISTER 11 0.0002
694 ANAPHYLACTIC SHOCK 5 0.0002
695 POOR VENOUS ACCESS 2 0.0002
696 VENTRICULAR EXTRASYSTOLES 2 0.0002
697 THERAPY PARTIAL RESPONDER 3 0.0002
698 SUDDEN DEATH 2 0.0002
699 ASPIRATION 2 0.0002
700 DRUG LEVEL INCREASED 3 0.0002
701 MEDICATION ERROR 10 0.0002
702 INTESTINAL PERFORATION 2 0.0002
703 NEPHROPATHY TOXIC 2 0.0002
704 MYOCARDIAL ISCHAEMIA 2 0.0002
705 CARDIAC VALVE DISEASE 1 0.0002
706 PRODUCT SUBSTITUTION ISSUE 10 0.0002
707 BLOOD CREATINE PHOSPHOKINASE INCREASED 5 0.0002
708 MUSCLE TWITCHING 4 0.0002
709 PRODUCT USE ISSUE 32 0.0002
710 OSTEOMYELITIS 3 0.0002
711 APHASIA 5 0.0002
712 RESTLESSNESS 6 0.0002
713 ENCEPHALOPATHY 4 0.0002
714 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
715 GENERALISED OEDEMA 2 0.0002
716 EXPOSURE DURING PREGNANCY 10 0.0002
717 OXYGEN SATURATION DECREASED 9 0.0002
718 LEUKOPENIA 8 0.0002
719 FOETAL EXPOSURE DURING PREGNANCY 13 0.0002
720 DYSARTHRIA 6 0.0002
721 HYPOCALCAEMIA 3 0.0002
722 CARDIOVASCULAR DISORDER 4 0.0002
723 GASTROINTESTINAL DISORDER 14 0.0002
724 GENERAL PHYSICAL HEALTH DETERIORATION 18 0.0002
725 MYOCARDIAL INFARCTION 27 0.0002
726 ASPERGILLUS INFECTION 1 0.0002
727 EYE DISORDER 5 0.0002
728 IMMUNE SYSTEM DISORDER 2 0.0002
729 PULMONARY CONGESTION 2 0.0002
730 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
731 JOINT RANGE OF MOTION DECREASED 2 0.0001
732 BRONCHIECTASIS 1 0.0001
733 CEREBROVASCULAR ACCIDENT 25 0.0001
734 OEDEMA 8 0.0001
735 COMA 7 0.0001
736 CHEST PAIN 27 0.0001
737 PNEUMONIA 47 0.0001
738 CONDITION AGGRAVATED 44 0.0001
739 HYPOMAGNESAEMIA 2 0.0001
740 MASS 2 0.0001
741 LUNG DISORDER 7 0.0001
742 HEPATOCELLULAR INJURY 2 0.0001
743 CONVULSION 8 0.0001
744 HYPOKINESIA 2 0.0001
745 CHEST DISCOMFORT 14 0.0001
746 ACCIDENTAL OVERDOSE 5 0.0001
747 CEREBRAL DISORDER 1 0.0001
748 TACHYCARDIA 12 0.0001
749 TRANSAMINASES INCREASED 3 0.0001
750 RENAL INJURY 4 0.0001
751 MATERNAL EXPOSURE DURING PREGNANCY 12 0.0001
752 COLON CANCER 2 0.0001
753 THERAPY NON-RESPONDER 6 0.0001
754 PANCREATITIS ACUTE 3 0.0001
755 CONTRAINDICATED PRODUCT ADMINISTERED 4 0.0001
756 EPILEPSY 4 0.0001
757 DRUG ADMINISTRATION ERROR 4 0.0001
758 PHARYNGEAL OEDEMA 2 0.0001
759 DEVICE RELATED INFECTION 2 0.0001
760 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 1 0.0001
761 LUNG INFECTION 2 0.0001
762 DRUG-INDUCED LIVER INJURY 4 0.0001
763 ULCER 2 0.0001
764 METABOLIC ACIDOSIS 4 0.0001
765 LOSS OF CONSCIOUSNESS 16 0.0001
766 BLOOD DISORDER 1 0.0001
767 SENSORY DISTURBANCE 2 0.0001
768 HYPONATRAEMIA 7 0.0001
769 MUSCLE TIGHTNESS 2 0.0001
770 BLOOD POTASSIUM INCREASED 2 0.0001
771 ESCHERICHIA INFECTION 1 0.0001
772 FEBRILE NEUTROPENIA 8 0.0001
773 CANDIDA INFECTION 2 0.0001
774 HEPATIC ENZYME INCREASED 8 0.0001
775 SCAR 2 0.0001
776 DYSPHAGIA 11 0.0001
777 OVERDOSE 25 0.0001
778 CARDIAC MURMUR 1 0.0001
779 DEAFNESS 3 0.0001
780 C-REACTIVE PROTEIN INCREASED 4 0.0001
781 DISEASE PROGRESSION 13 0.0001
782 AGITATION 8 0.0001
783 BRAIN NEOPLASM 1 0.0001
784 RESPIRATORY ARREST 3 0.0001
785 RENAL DISORDER 5 0.0001
786 BACTERIAL INFECTION 2 0.0001
787 ARTERIOSCLEROSIS 1 0.0001
788 ABORTION INDUCED 1 0.0001
789 BLOOD SODIUM DECREASED 2 0.0001
790 UNEVALUABLE EVENT 8 0.0001
791 ARRHYTHMIA 5 0.0001
792 RED BLOOD CELL COUNT DECREASED 3 0.0001
793 ANGINA PECTORIS 3 0.0001
794 PULMONARY FIBROSIS 2 0.0001
795 CHOLESTASIS 2 0.0001
796 PRESCRIBED OVERDOSE 2 0.0001
797 DIZZINESS POSTURAL 1 0.0001
798 DISORIENTATION 4 0.0001
799 ABDOMINAL PAIN 23 0.0001
800 OEDEMA PERIPHERAL 12 0.0001
801 SPEECH DISORDER 5 0.0001
802 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
803 DRUG EFFECT DECREASED 5 0.0001
804 PRODUCT USE IN UNAPPROVED INDICATION 23 0.0001
805 DECREASED ACTIVITY 1 0.0001
806 FAECES DISCOLOURED 2 0.0001
807 AMNESIA 6 0.0001
808 VAGINAL HAEMORRHAGE 4 0.0001
809 SWELLING FACE 6 0.0001
810 ANGIOEDEMA 4 0.0001
811 STEVENS-JOHNSON SYNDROME 2 0.0001
812 HEPATOTOXICITY 2 0.0001
813 NECK PAIN 5 0.0001
814 NO ADVERSE EVENT 16 0.0001
815 NEUTROPENIA 12 0.0001
816 ELECTROLYTE IMBALANCE 1 0.0001
817 HEART RATE DECREASED 3 0.0001
818 COVID-19 PNEUMONIA 1 0.0001
819 CHOLECYSTITIS 1 0.0001
820 ELECTROCARDIOGRAM QT PROLONGED 3 0.0001
821 INTERSTITIAL LUNG DISEASE 4 0.0001
822 MENTAL IMPAIRMENT 2 0.0001
823 HYPOGLYCAEMIA 4 0.0001
824 CARDIOMEGALY 1 0.0001
825 PRODUCT QUALITY ISSUE 11 0.0001
826 SYNCOPE 8 0.0001
827 INTENTIONAL PRODUCT USE ISSUE 7 0.0001
828 DERMATITIS ALLERGIC 1 0.0001
829 DYSPNOEA 45 0.0001
830 CELLULITIS 4 0.0001
831 CHRONIC KIDNEY DISEASE 6 0.0001
832 HYPERHIDROSIS 10 0.0001
833 ANOREXIA 1 0.0001
834 SKIN ULCER 2 0.0001
835 JOINT STIFFNESS 2 0.0001
836 SWELLING 7 0.0001
837 JAUNDICE 2 0.0001
838 CONFUSIONAL STATE 12 0.0001
839 THROAT TIGHTNESS 2 0.0001
840 PALLOR 2 0.0001
841 PYREXIA 25 0.0001
842 FEELING COLD 2 0.0001
843 COORDINATION ABNORMAL 1 0.0001
844 PANCYTOPENIA 4 0.0001
845 DEMENTIA 2 0.0001
846 WOUND 2 0.0001
847 HEART RATE INCREASED 7 0.0001
848 MUSCULAR WEAKNESS 8 0.0001
849 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
850 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
851 LABORATORY TEST ABNORMAL 2 0.0001
852 PSYCHOTIC DISORDER 2 0.0001
853 WHEEZING 4 0.0001
854 THERAPEUTIC PRODUCT EFFECT DECREASED 3 0.0001
855 ECONOMIC PROBLEM 1 0.0001
856 BLOOD COUNT ABNORMAL 1 0.0001
857 DRUG DISPENSING ERROR 1 0.0001
858 HYPOKALAEMIA 3 0.0001
859 FEMUR FRACTURE 2 0.0001
860 CARDIAC DISORDER 6 0.0001
861 NERVOUS SYSTEM DISORDER 2 0.0001
862 RASH ERYTHEMATOUS 3 0.0001
863 HYPOTHYROIDISM 2 0.0001
864 CHOLELITHIASIS 2 0.0001
865 CYTOMEGALOVIRUS INFECTION 1 0.0001
866 ANXIETY 17 0.0001
867 HYPERSENSITIVITY 11 0.0001
868 DEATH 51 0.0001
869 DRUG EXPOSURE DURING PREGNANCY 2 0.0001
870 URINARY TRACT INFECTION 10 0.0001
871 ERYTHEMA 12 0.0001
872 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
873 AMENORRHOEA 1 0.0001
874 HYPERTENSION 12 0.0001
875 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
876 DRUG ERUPTION 1 0.0001
877 COMPLICATION OF DEVICE REMOVAL 1 0.0001
878 WRONG TECHNIQUE IN DRUG USAGE PROCESS 2 0.0001
879 HYPERGLYCAEMIA 2 0.0001
880 BONE DISORDER 1 0.0001
881 PANIC ATTACK 2 0.0001
882 END STAGE RENAL DISEASE 1 0.0001
883 BRONCHITIS 4 0.0001
884 BLOOD URINE PRESENT 1 0.0001
885 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
886 CHOKING 1 0.0001
887 DISABILITY 1 0.0001
888 VERTIGO 3 0.0000
889 BONE MARROW FAILURE 1 0.0000
890 DISCOMFORT 3 0.0000
891 NEUTROPHIL COUNT DECREASED 2 0.0000
892 BODY TEMPERATURE INCREASED 1 0.0000
893 VOMITING 23 0.0000
894 OSTEOPOROSIS 2 0.0000
895 RASH 21 0.0000
896 ABDOMINAL DISTENSION 5 0.0000
897 SKIN EXFOLIATION 4 0.0000
898 EATING DISORDER 1 0.0000
899 MENTAL DISORDER 2 0.0000
900 MUSCULOSKELETAL STIFFNESS 4 0.0000
901 INFUSION RELATED REACTION 3 0.0000
902 SEIZURE 5 0.0000
903 PRODUCTIVE COUGH 2 0.0000
904 MOBILITY DECREASED 3 0.0000
905 BLOOD PRESSURE FLUCTUATION 1 0.0000
906 TOXICITY TO VARIOUS AGENTS 7 0.0000
907 EMOTIONAL DISTRESS 5 0.0000
908 PAIN IN EXTREMITY 12 0.0000
909 NAUSEA 31 0.0000
910 THERAPY CESSATION 2 0.0000
911 DIPLOPIA 1 0.0000
912 NERVOUSNESS 2 0.0000
913 MUSCULOSKELETAL PAIN 2 0.0000
914 PANCREATITIS 2 0.0000
915 INJECTION SITE HAEMORRHAGE 3 0.0000
916 BLOOD GLUCOSE INCREASED 7 0.0000
917 DIVERTICULITIS 1 0.0000
918 URTICARIA 6 0.0000
919 ASTHMA 4 0.0000
920 LETHARGY 2 0.0000
921 INFECTION 5 0.0000
922 PRODUCT STORAGE ERROR 3 0.0000
923 DYSSTASIA 1 0.0000
924 DYSPHONIA 2 0.0000
925 CHILLS 4 0.0000
926 HYPOAESTHESIA 5 0.0000
927 FEELING HOT 2 0.0000
928 EMOTIONAL DISORDER 1 0.0000
929 PARAESTHESIA 5 0.0000
930 NEUROPATHY PERIPHERAL 3 0.0000
931 CYSTITIS 1 0.0000
932 GAIT DISTURBANCE 6 0.0000
933 PRURITUS 12 0.0000
934 CONTUSION 3 0.0000
935 PAIN 19 0.0000
936 HEADACHE 19 0.0000
937 BACK PAIN 7 0.0000
938 TREMOR 5 0.0000
939 FALL 10 0.0000
940 DEHYDRATION 4 0.0000
941 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
942 FLUSHING 3 0.0000
943 DIARRHOEA 19 0.0000
944 ASTHENIA 11 0.0000
945 VISION BLURRED 4 0.0000
946 COUGH 8 0.0000
947 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
948 DIZZINESS 14 0.0000
949 THERAPY INTERRUPTED 2 0.0000
950 SKIN BURNING SENSATION 2 0.0000
951 WHITE BLOOD CELL COUNT DECREASED 3 0.0000
952 CONSTIPATION 6 0.0000
953 DYSPNOEA EXERTIONAL 1 0.0000
954 INSOMNIA 7 0.0000
955 BLOOD PRESSURE INCREASED 4 0.0000
956 PERIPHERAL SWELLING 4 0.0000
957 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
958 BLINDNESS 1 0.0000
959 BALANCE DISORDER 2 0.0000
960 COLITIS ULCERATIVE 1 0.0000
961 MUSCLE SPASMS 4 0.0000
962 OROPHARYNGEAL PAIN 2 0.0000
963 COGNITIVE DISORDER 1 0.0000
964 DRUG INTOLERANCE 2 0.0000
965 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
966 ARTHRALGIA 8 0.0000
967 ECZEMA 1 0.0000
968 ARTHROPATHY 1 0.0000
969 DEPRESSION 4 0.0000
970 COVID-19 3 0.0000
971 BONE PAIN 1 0.0000
972 VISUAL IMPAIRMENT 2 0.0000
973 FATIGUE 12 0.0000
974 ALOPECIA 3 0.0000
975 ABDOMINAL PAIN UPPER 3 0.0000
976 BURNING SENSATION 1 0.0000
977 DEVICE MALFUNCTION 1 0.0000
978 DYSGEUSIA 1 0.0000
979 INCORRECT DOSE ADMINISTERED 3 0.0000
980 DIABETES MELLITUS 1 0.0000
981 DECREASED APPETITE 3 0.0000
982 ARTHRITIS 1 0.0000
983 FEELING ABNORMAL 3 0.0000
984 ADVERSE DRUG REACTION 1 0.0000
985 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
986 ADVERSE EVENT 1 0.0000
987 WEIGHT DECREASED 3 0.0000
988 DYSPEPSIA 1 0.0000
989 SOMNOLENCE 2 0.0000
990 MALAISE 4 0.0000
991 WEIGHT INCREASED 2 0.0000
992 ABDOMINAL DISCOMFORT 1 0.0000